» Articles » PMID: 26251007

Endocytosis of Ubiquitylation-Deficient EGFR Mutants Via Clathrin-Coated Pits is Mediated by Ubiquitylation

Overview
Journal Traffic
Publisher Wiley
Specialties Biology
Physiology
Date 2015 Aug 8
PMID 26251007
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Signaling by epidermal growth factor receptor (EGFR) is controlled by endocytosis. However, mechanisms of EGFR endocytosis remain poorly understood. Here, we found that the EGFR mutant lacking known ubiquitylation, acetylation and clathrin adaptor AP-2-binding sites (21KRΔAP2) was internalized at relatively high rates via the clathrin-dependent pathway in human duodenal adenocarcinoma HuTu-80 cells. RNA interference analysis revealed that this residual internalization is strongly inhibited by depletion of Grb2 and the E2 ubiquitin-conjugating enzyme UbcH5b/c, and partially affected by depletion of the E3 ubiquitin ligase Cbl and ubiquitin-binding adaptors, indicating that an ubiquitylation process is involved. Several new ubiquitin conjugation sites were identified by mass spectrometry in the 21KRΔAP2 mutant, suggesting that cryptic ubiquitylation may mediate endocytosis of this mutant. Total internal reflection fluorescence microscopy imaging of HuTu-80 cells transfected with labeled ubiquitin adaptor epsin1 demonstrated that the ubiquitylation-deficient EGFR mutant was endocytosed through a limited population of epsin-enriched clathrin-coated pits (CCPs), although with a prolonged CCP lifetime. Native EGFR was recruited with the same efficiency into CCPs containing either AP-2 or epsin1 that were tagged with fluorescent proteins by genome editing of MDA-MD-231 cells. We propose that two redundant mechanisms, ubiquitylation and interaction with AP-2, contribute to EGFR endocytosis via CCPs in a stochastic fashion.

Citing Articles

Cbl and Cbl-b independently regulate EGFR through distinct receptor interaction modes.

Pinilla-Macua I, Sorkin A Mol Biol Cell. 2023; 34(13):ar134.

PMID: 37903221 PMC: 10848940. DOI: 10.1091/mbc.E23-02-0058.


Hypoxic stress disrupts HGF/Met signaling in human trophoblasts: implications for the pathogenesis of preeclampsia.

Li G, Wang Y, Cao G, Ma Y, Li Y, Zhao Y J Biomed Sci. 2022; 29(1):8.

PMID: 35114998 PMC: 8815204. DOI: 10.1186/s12929-022-00791-5.


ANTH domains within CALM, HIP1R, and Sla2 recognize ubiquitin internalization signals.

Pashkova N, Gakhar L, Yu L, Schnicker N, Minard A, Winistorfer S Elife. 2021; 10.

PMID: 34821552 PMC: 8648300. DOI: 10.7554/eLife.72583.


Mechanism of p38 MAPK-induced EGFR endocytosis and its crosstalk with ligand-induced pathways.

Perez Verdaguer M, Zhang T, Paulo J, Gygi S, Watkins S, Sakurai H J Cell Biol. 2021; 220(7).

PMID: 34032851 PMC: 8155814. DOI: 10.1083/jcb.202102005.


Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.

Crotchett B, Ceresa B Pharmacol Res Perspect. 2021; 9(2):e00756.

PMID: 33811466 PMC: 8019067. DOI: 10.1002/prp2.756.


References
1.
Lemmon M, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell. 2010; 141(7):1117-34. PMC: 2914105. DOI: 10.1016/j.cell.2010.06.011. View

2.
Sigismund S, Confalonieri S, Ciliberto A, Polo S, Scita G, Di Fiore P . Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev. 2012; 92(1):273-366. PMC: 5614474. DOI: 10.1152/physrev.00005.2011. View

3.
Heukers R, Vermeulen J, Fereidouni F, Bader A, Voortman J, Roovers R . Endocytosis of EGFR requires its kinase activity and N-terminal transmembrane dimerization motif. J Cell Sci. 2013; 126(Pt 21):4900-12. DOI: 10.1242/jcs.128611. View

4.
Woelk T, Oldrini B, Maspero E, Confalonieri S, Cavallaro E, Di Fiore P . Molecular mechanisms of coupled monoubiquitination. Nat Cell Biol. 2006; 8(11):1246-54. DOI: 10.1038/ncb1484. View

5.
Umebayashi K, Stenmark H, Yoshimori T . Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell. 2008; 19(8):3454-62. PMC: 2488299. DOI: 10.1091/mbc.e07-10-0988. View